FDA Inspection 1202930 — Russell A. Foulk, MD
The FDA completed an inspection of Russell A. Foulk, MD on March 17, 2023 in Pleasant Grove, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pleasant Grove, UT (United States)
Additional Details
Clinical Investigator (CI)